Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Hepion Pharmaceuticals (HEPA) stocks in Canada
Learn how to easily invest in Hepion Pharmaceuticals stocks.
Hepion Pharmaceuticals is a biotechnology business based in the US. Hepion Pharmaceuticals stocks (HEPA.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.1 – a decrease of 7.96% over the previous week. Hepion Pharmaceuticals employs 13 staff and has a market cap (total outstanding stock value) of $71.7 million.
How to buy shares in Hepion Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – HEPA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Hepion Pharmaceuticals?
- Has coronavirus impacted Hepion Pharmaceuticals shares?
- Hepion Pharmaceuticals shares summary
- Compare share dealing platforms
- Is Hepion Pharmaceuticals stock a buy or sell?
- Hepion Pharmaceuticals performance over time
- Hepion Pharmaceuticals's financials
- How volatile are Hepion Pharmaceuticals shares?
- Does Hepion Pharmaceuticals pay a dividend?
- Have Hepion Pharmaceuticals shares ever split?
- Other common questions
Hepion Pharmaceuticals stock price (NASDAQ:HEPA)Use our graph to track the performance of HEPA stocks over time.
Hepion Pharmaceuticals shares at a glance
|Latest market close||$0.93|
|52-week range||$0.86 - $3.18|
|50-day moving average||$1.24|
|200-day moving average||$1.56|
|Wall St. target price||$5.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.50|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Hepion Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Hepion Pharmaceuticals price performance over time
|1 week (2022-01-21)||-7.96%|
|1 month (2021-12-25)||N/A|
|3 months (2021-10-29)||-34.99%|
|6 months (2021-07-29)||-39.64%|
|1 year (2021-01-29)||-54.87%|
|2 years (2020-01-28)||-81.33%|
|3 years (2019-01-28)||190.50%|
|5 years (2017-01-27)||1.43|
Hepion Pharmaceuticals financials
|Gross profit TTM||$0|
|Return on assets TTM||-24.97%|
|Return on equity TTM||-48.38%|
|Market capitalisation||$71.7 million|
TTM: trailing 12 months
Hepion Pharmaceuticals share dividends
We're not expecting Hepion Pharmaceuticals to pay a dividend over the next 12 months.
Have Hepion Pharmaceuticals's shares ever split?
Hepion Pharmaceuticals's shares were split on a 1:70 basis on 3 June 2019. So if you had owned 70 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Hepion Pharmaceuticals shares – just the quantity. However, indirectly, the new 6900% higher share price could have impacted the market appetite for Hepion Pharmaceuticals shares which in turn could have impacted Hepion Pharmaceuticals's share price.
Hepion Pharmaceuticals share price volatility
Over the last 12 months, Hepion Pharmaceuticals's shares have ranged in value from as little as $0.862 up to $3.18. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Hepion Pharmaceuticals's is 1.3817. This would suggest that Hepion Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Hepion Pharmaceuticals overview
Hepion Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing CRV431, a cyclophilin inhibitor that is in Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc.
Stocks similar to Hepion Pharmaceuticals
Hepion Pharmaceuticals in the news
Hepion Pharmaceuticals Rencofilstat, in Combination with an Immune Checkpoint Inhibitor, Demonstrates Synergistic Anti-Tumor Activity in a Nonclinical Liver Cancer Study
XBI: The Worst Is Over
Health Care Sector Update for 01/26/2022: ALGS,IMCR,HEPA,TYME
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Ask an Expert
You must be logged in to post a comment.